442-A Optimization and validation of novel chimeric antigen receptor (CARs) architectures for the treatment of leukemia and beyond
Main Authors: | Etienne Gagnon, Margaux Tual |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Chimeric Antigen Receptor beyond CAR-T Cells
by: Vicky Mengfei Qin, et al.
Published: (2021-01-01) -
Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations
by: Beatriz Guijarro-Albaladejo, et al.
Published: (2024-04-01) -
Chimeric antigen receptor T (CAR‐T) cells: Novel cell therapy for hematological malignancies
by: Samane Abbasi, et al.
Published: (2023-04-01) -
Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)
by: Utkarsh H. Acharya, et al.
Published: (2020-12-01) -
Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)—T Cells
by: Ali Hosseini Rad S. M., et al.
Published: (2021-03-01)